PRTN3 and rheumatoid arthritis: A case-control study conducted by the Swedish Epidemiological Investigation of RA (EIRA) found no evidence of an increased prevalence of PD in established RA patients compared to healthy controls, and no differences on the basis of anti-citrullinated protein antibody (ACPA) or rheumatoid factor (RF) status among RA patients (43).